This will involve moving its first cancer drug into clinical ... “Since the molecule is macrophage targeted, we don’t affect T-cells, which you would do with a normal p38 inhibitor.” ...
The immune system plays a pivotal role in colorectal cancer (CRC), with immune cells such as T cells, natural killer (NK) cells, macrophages, and dendritic ...
In their laboratory testing, the biomedical engineers combined breast cancer cells and macrophages loaded with the nanoparticles. Once they added ascorbic acid, the tumor-killing effect was ...
which can invade the tumor and attack cancer cells. However, another type of immune cell, macrophages—sometimes called the "policemen" of cancer tissue—can block T-cells from working effectively.